SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-038417
Filing Date
2024-03-29
Accepted
2024-03-29 08:15:33
Documents
74
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A pepg-20231231.htm   iXBRL 10-K/A 1363291
2 EX-23.1 pepg-ex23_1.htm EX-23.1 2588
3 EX-31.3 pepg-ex31_3.htm EX-31.3 10029
4 EX-31.4 pepg-ex31_4.htm EX-31.4 9690
5 EX-32.3 pepg-ex32_3.htm EX-32.3 9044
6 EX-32.4 pepg-ex32_4.htm EX-32.4 9075
  Complete submission text file 0000950170-24-038417.txt   7764257

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pepg-20231231.xsd EX-101.SCH 1284418
78 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20231231_htm.xml XML 1338451
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41374 | Film No.: 24802082
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)